News FDA hands out first national priority vouchers to nine firms The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher programme.
News Merck looking to rare disease deals to build health momentum Germany's Merck KGaA is looking at making further acquisitions to boost its business, with a focus on life sciences and rare diseases.
News J&J faces fresh litigation in UK over talc cancer risks Thousands of people in the UK have joined a lawsuit against Johnson & Johnson, claiming that it knowingly sold talc products that caused cancer.
News Bavarian Nordic urges investors to accept takeover offer A private equity investment consortium has raised a takeover offer for Denmark's Bavarian Nordic, but some shareholders are still reluctant to sell.
News Novo builds pipeline again with $2.1bn Omeros deal Novo Nordisk has boosted its pipeline by paying $340m upfront for rights to an Omeros drug for PNH and other rare blood and kidney disorders.
News UK's VR-powered medicine maker scheme delivers first results A UK initiative to train a new generation of workers in medicines manufacturing has been taken up by around 1,200 people since it started last year.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.